The FDA accepts and grants priority review to Merck's sNDA for Welireg to treat advanced pheochromocytoma and paraganglioma.

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and ...

The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA ...

MAHTAB SOHREVARDI ENDOCRINOLOGY Physician Huntington Health Dr. Mahtab Sohrevardi’s area of interest is thyroidal disorders ...

CATLETTSBURG Rusty was royalty. Catlettsburg Elementary treated one of its third-graders like a prince on Thursday morning as ...

A former WWE star has announced her exit from AEW. She has been absent on TV for several months.

Maria Kanellis is departing AEW with her contract expiring at the end of January. Kanellis sent out a message on her social ...

Is your dog suddenly lethargic, losing weight, or vomiting? It could be Addison’s disease! Learn the signs, risks, and ...

The US Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application (sNDA) for ...